Skip to main content

Tissue Toxicity in Experimental Isolated Perfusion with Adriamycin

  • Chapter
Vascular Perfusion in Cancer Therapy

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 86))

Abstract

Since the introduction of isolated regional perfusion in 1958 by Creech et al. this method has been employed for the treatment of various tumors of the extremities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aigner K, Schwemmle K (to be published) Technik der isolierten Extremitätenperfusion — Erfahrungen an 171 Fällen. Langenbecks Arch Chir

    Google Scholar 

  • Braat RP, van Slooten E, Wieberdink K, Olthuis J (1981) Regional perfusion with adriamycin in soft tissue sarcomas. EORTC Melanoma Meeting, 26–28 Oct 1981, Lausanne

    Google Scholar 

  • Carter SK (1980) The clinical evaluation of analogs. III. Anthracyclines. Cancer Chemother Pharmacol 4: 5–10

    CAS  Google Scholar 

  • Creech O, Krementz ET, Ryan RF, Winblad JM (1958) Chemotherapy of cancer: Regional perfusion utilizing an extracorporal circuit. Ann Surg 148: 616–632

    Article  PubMed  Google Scholar 

  • DiPietro S, DePalo G, Gennari L (1973) Cancer chemotherapy by intra-arterial infusion with adriamycin. J Surg Oncol 5: 421–430

    Article  CAS  Google Scholar 

  • Gottlieb JA, Baker LH, O’Bryan RM, Sinkovics JG, Hoogstraten B, Quagliana JM, Rivkin SE, Bodey GP, Rodriguez VT, Blumenschein GR, Saiki JH, Coltman C, Burgess MA, Sullivan P, Thigpen T, Bottomley R, Balcerzak S, Moon TE (1975) Adriamycin (NSC-123127) used alone and in combination for soft tissue and bony sarcomas. Cancer Chemother Rep 6: 271–283

    Google Scholar 

  • Haskel CM, Silverstein MJ, Rangel DM (1974) Multimodality cancer therapy in man: a pilot study of adriamycin by arterial infusion. Cancer 33: 1485–1490

    Article  Google Scholar 

  • Haskel CM, Eilber FR, Morton DL (1975) Adriamycin (NSC-123127) by arterial infusion. Cancer Chemother Rep 6: 187–189

    Google Scholar 

  • O’Bryan RM, Baker LH, Gottlieb JE, Rivkin SE, Balcerzak SP, Grumet GN, Salmon SE, Moon TE, Hoogstraten B (1977) Dose-response evaluation of adriamycin in human neoplasia. Cancer 39: 1940–1948

    Article  PubMed  Google Scholar 

  • Schraffordt Koops H, Eibergen R, Oldhoff J, van der Ploeg E, Vermey A (1976) Isolated regional perfusion in the treatment of soft tissue sarcomas of the extremities. Clin Oncol 2: 245–252

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Henneking, K., Aigner, K., Deeg, C., Merker, G., Spelz, H.W., Hundeiker, M. (1983). Tissue Toxicity in Experimental Isolated Perfusion with Adriamycin. In: Schwemmle, K., Aigner, K. (eds) Vascular Perfusion in Cancer Therapy. Recent Results in Cancer Research, vol 86. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82025-0_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82025-0_42

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-82027-4

  • Online ISBN: 978-3-642-82025-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics